₹1,553
▼ -0.93 -0.06%
17 Jul 2026
NSE Listed · Healthcare
Jupiter Life Line Hosp Limited (JLHL)
Volume: 2,165Avg Vol 1W: 42,158Avg Vol 1M: 68,26552W Range:₹1,178₹1,625
Key Ratios
Checked just nowMarket Cap₹10,182 Cr
Current Price₹1,553
Previous Close₹1,553.93
High / Low (52w)₹1,625 / ₹1,178
Volume2,165
Avg Vol (1W)42,158
Avg Vol (1M)68,265
Stock P/E53.77
Book Value₹235.5
Dividend Yield6%
ROE12.56%
ROA8.15%
Revenue (TTM)—
Revenue Growth17.52%
Profit Margin12.94%
Total Debt₹322 Cr
Shares Outstanding7 Cr
Face Value₹10
EPS (TTM)₹28.88
P/B6.59
Debt / Equity0.34
50 DMA₹1,418.72
200 DMA₹1,312
Day change-0.06%
Price Chart
₹1,553▲ 9.74% · 1Y
2025-11-242026-07-17
20-day avg volume: 74K shares
Pros
- Pays a dividend yield of 6.0%.
- Company is almost debt-free.
- Revenue grew 16% YoY.
Cons
- Stock trades at a high P/E of 54.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹289 Cr | ₹335 Cr | ₹333 Cr | ₹337 Cr | ₹353 Cr | ₹394 Cr | ₹365 Cr | ₹388 Cr |
| EBITDA | ₹61 Cr | ₹71 Cr | ₹70 Cr | ₹69 Cr | ₹70 Cr | ₹82 Cr | ₹71 Cr | ₹75 Cr |
| Net Profit | ₹44 Cr | ₹52 Cr | ₹52 Cr | ₹45 Cr | ₹44 Cr | ₹57 Cr | ₹43 Cr | ₹50 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹465 Cr | ₹490 Cr | ₹737 Cr | ₹903 Cr | ₹1,095 Cr | ₹1,331 Cr | ₹1,542 Cr |
| EBITDA | ₹59 Cr | ₹41 Cr | ₹121 Cr | ₹173 Cr | ₹222 Cr | ₹271 Cr | ₹298 Cr |
| Net Profit | ₹30 Cr | ₹-2 Cr | ₹51 Cr | ₹73 Cr | ₹177 Cr | ₹193 Cr | ₹194 Cr |
| EPS | 5.83 | -0.45 | 10.05 | 12.9 | 28.44 | 29.47 | 29.59 |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹603 Cr | ₹789 Cr | ₹909 Cr | ₹986 Cr | ₹1,281 Cr | ₹1,936 Cr | ₹2,383 Cr |
| Total Liabilities | ₹366 Cr | ₹542 Cr | ₹620 Cr | ₹622 Cr | ₹113 Cr | ₹579 Cr | ₹839 Cr |
| Equity | ₹237 Cr | ₹246 Cr | ₹288 Cr | ₹364 Cr | ₹1,169 Cr | ₹1,356 Cr | ₹1,544 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | ₹89 Cr | ₹133 Cr | ₹146 Cr | ₹196 Cr | ₹164 Cr | ₹331 Cr | ₹332 Cr |
| Investing | ₹-43 Cr | ₹-296 Cr | ₹-85 Cr | ₹-94 Cr | ₹-246 Cr | ₹-497 Cr | ₹-442 Cr |
| Financing | ₹-32 Cr | ₹184 Cr | ₹32 Cr | ₹-51 Cr | ₹128 Cr | ₹297 Cr | ₹136 Cr |
| Free Cash Flow | ₹89 Cr | ₹133 Cr | ₹146 Cr | ₹196 Cr | ₹164 Cr | ₹331 Cr | ₹332 Cr |
Shareholding
Promoter 40.91% Institutions 25.49% Public 33.6%
Efficiency & Working Capital
ROCE13.8%
Interest Coverage9
Dividend Payout—
Debtor Days18 d
Inventory Days9 d
Payable Days23 d
Cash Conversion Cycle4 d
Working Capital Days28 d
Shareholding Details
As of 2026-03-31
Promoter40.9%
FII8.5%
DII17%
Institutions25.5%
Public33.6%
Promoter Pledge0%
No. of Shareholders32,985
Shareholding Pattern
Quarterly — figures in %. Latest 11 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 40.9% | 40.9% | 40.9% | 40.9% | 40.9% | 40.9% | 40.9% | 40.9% | 40.9% | 40.9% | 40.9% |
| FIIs | 4.6% | 4% | 4.2% | 6.1% | 8.8% | 10% | 10% | 9.8% | 9.1% | 8.5% | 8.5% |
| DIIs | 12.3% | 13.6% | 17.6% | 17.3% | 16.9% | 15.7% | 15.6% | 15.8% | 17% | 17.4% | 17% |
| Public | 42.1% | 41.5% | 37.3% | 35.8% | 33.4% | 33.3% | 33.4% | 33.5% | 33.1% | 33.2% | 33.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 54,782 | 39,348 | 35,107 | 35,797 | 34,081 | 33,914 | 33,956 | 34,192 | 34,361 | 33,620 | 32,985 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Ajay Pratap Thakker | Shareholding of Promoter and Promoter Group | 20.7% | 1.36 Cr |
| Western Medical Solutions Llp | Shareholding of Promoter and Promoter Group | 8.7% | 57,03,797 |
| Sbi Healthcare Opportunities Fund | Public Shareholding | 7.8% | 50,96,817 |
| Ankit Ajay Thakker | Shareholding of Promoter and Promoter Group | 6.7% | 43,75,789 |
| Jm Financial Products Limited | Public Shareholding | 3.4% | 22,40,000 |
| Goldman Sachs Funds-goldman Sachs India Equity P | Public Shareholding | 2.8% | 18,05,856 |
| Sbi Life Insurance Co.ltd | Public Shareholding | 2.5% | 16,08,738 |
| Mihir Wire Industries Pvt Ltd | Public Shareholding | 2.2% | 14,10,000 |
| Neeta Devang Gandhi | Shareholding of Promoter and Promoter Group | 2.1% | 13,80,000 |
| Kirtika Ajay Thakker | Shareholding of Promoter and Promoter Group | 2% | 13,32,750 |
| Dr Navin Ramji Davda | Public Shareholding | 2% | 13,10,700 |
| Jm Financial And Investment Consultancy Services | Public Shareholding | 1.9% | 12,50,000 |
| Ramakant Jagdish Tibrewala | Public Shareholding | 1.9% | 12,25,000 |
| Nitin Manilal Thakker | Public Shareholding | 1.9% | 12,20,000 |
| Mahesh Ramakant Tibrewala | Public Shareholding | 1.8% | 11,81,736 |
| Brijesh Ramakant Tibrewala | Public Shareholding | 1.8% | 11,81,772 |
| Kamini A Rao | Public Shareholding | 1.6% | 10,66,975 |
| Snk Investments Private Limited | Public Shareholding | 1.4% | 9,10,000 |
| Vyshnavi Rao | Public Shareholding | 1.2% | 8,05,980 |
| Sushma Ramakant Tibrewala | Public Shareholding | 1.2% | 8,00,750 |
| Mitul Nitin Thakker | Public Shareholding | 1.2% | 7,99,750 |
| Rajesh Hiralal Vora | Public Shareholding | 1.2% | 8,00,000 |
| Pooja Sidharth Rao | Public Shareholding | 1.2% | 7,64,311 |
| Darshana Mitesh Chothani | Public Shareholding | 1.1% | 7,19,378 |
| Girish Shamji Gala | Public Shareholding | 1% | 6,69,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Ankit Ajay Thakker | 0 | 0% | 2026-03-31 |
| Ajay P Thakker Huf | 0 | 0% | 2026-03-31 |
| Ajay Pratap Thakker | 0 | 0% | 2026-03-31 |
| Kirtika Ajay Thakker | 0 | 0% | 2026-03-31 |
| Sanjay Thakker | 0 | 0% | 2026-03-31 |
| Roopa Ganatra | 0 | 0% | 2026-03-31 |
| Avi Thakker | 0 | 0% | 2026-03-31 |
| Amit Jain | 0 | 0% | 2026-03-31 |
| Neera Jain | 0 | 0% | 2026-03-31 |
| Abhinav Jain | 0 | 0% | 2026-03-31 |
| Ankita Jain | 0 | 0% | 2026-03-31 |
| Devang Vasantlal Gandhi Huf | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| AJAY PRATAP THAKKER | Chairman & Managing Director | 2026 |
| Vadapatra Sayee Raghavan | Non-Exec & Non-Independent Dir | 2026 |
| Satish Utekar | Independent Non Exe. Director | 2026 |
| ANKIT AJAY THAKKER | ED / Joint MD / CEO / Promoter | 2026 |
| DARSHAN HIRALAL VORA | Independent Non Exe. Director | 2026 |
| Urmi Popat | Independent Non Exe. Director | 2026 |
| JASMIN A PATEL | Independent Non Exe. Director | 2026 |
| Amar Manjrekar | Independent Non Exe. Director | 2026 |
| Suma Upparatti | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Healthcare services | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 80 | 66 | 66 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2026-05-22 | ₹1 (10%) | Interim |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 140 | 0 | 0 | 12 | 9 | 161 |
| 2026 | 13 | 0 | 0 | 0 | 6 | 18 |
| 2026 | 126 | 0 | 0 | 12 | 3 | 142 |
Substantial Acquisitions (SAST)
1 disclosure(s)
Market18/09/2023 · 39,65,000
Company Information
Incorporated2002
ChairmanAJAY PRATAP THAKKER
AuditorAswin P Malde & Co/KKC & Associates LLP
Investor Email[email protected]
📍 1004 Xth Flr 360 Degree Busi., Park LBS Marg Mulund (West), Mumbai, Maharashtra, 400080
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search